spirogermanium has been researched along with Breast Cancer in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blumenschein, GR; Bodey, GP; Legha, SS; Pinnamaneni, K; Yap, HY | 1 |
Chang, YC; Falkson, G; Harper, GR; Khandekar, JD; Kuebler, JP; Tormey, DC | 1 |
Cain, KC; Mehta, CR | 1 |
Falkson, G; Falkson, HC | 1 |
Budman, DR; Coleman, M; Ginsberg, S; Hanson, J; Perry, M; Schein, P; Weinberg, V; Wood, W | 1 |
5 other study(ies) available for spirogermanium and Breast Cancer
Article | Year |
---|---|
Phase II study of spirogermanium in the treatment of metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Central Nervous System Diseases; Drug Evaluation; Female; Germanium; Humans; Infusions, Parenteral; Middle Aged; Organometallic Compounds; Spiro Compounds | 1984 |
Phase II study of spirogermanium in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Female; Germanium; Humans; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Receptors, Estrogen; Spiro Compounds | 1984 |
Charts for the early stopping of pilot studies.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Esophageal Neoplasms; False Negative Reactions; Female; Germanium; Humans; Male; Models, Biological; Organometallic Compounds; Pilot Projects; Probability; Sampling Studies; Spiro Compounds; Time Factors | 1984 |
Phase II trial of spirogermanium for treatment of advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Drug Evaluation; Female; Germanium; Humans; Middle Aged; Organometallic Compounds; Spiro Compounds | 1983 |
Phase II trial of spirogermanium in breast adenocarcinoma: a Cancer and Leukemia Group B Study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Female; Germanium; Humans; Middle Aged; Organometallic Compounds; Spiro Compounds | 1982 |